Harvard Infectious Diseases In Adults 2025

Harvard Infectious Diseases In Adults 2025

$75.00

+ Include: 59 videos + 53 pdfs, size: 35.2 GB

+ Target Audience: infectious diseases physicians, internists, hospitalists, family physicians, pulmonologists, critical care physicians, emergency medicine physicians

Description

+ Include: 59 videos + 53 pdfs, size: 35.2 GB

+ Target Audience: infectious diseases physicians, internists, hospitalists, family physicians, pulmonologists, critical care physicians, emergency medicine physicians

+ Sample video: contact me for sample video

+ Information:

State-of-the-Art Approaches to Prevention, Diagnosis, and Treatment of Infectious Diseases

Infectious Diseases in Adults 2025 will be held online this year, using live streaming technology and live question and answer sessions. 

OVERVIEW

This comprehensive CME program ensures attendees are current with state-of-the-art approaches to prevention, diagnosis, and treatment of infectious diseases. Updates, best practices, and new guidelines are presented by nationally recognized ID experts and master clinicians. Education is practical and results-driven:

  • Optimal decision-making in the prevention, diagnosis, and treatment of infectious diseases
  • Newer antimicrobials and treatment strategies for highly resistant infections
  • Prevention and treatment of infections in immunocompromised hosts
  • Update on antifungal diagnostics and therapy
  • State-of-the-art and multidisciplinary approaches to common infections
  • Clinical approaches to complex, rare, and “don’t-miss” infections
  • New, evolving, emerging, and re-emerging infectious diseases
  • Infections in persons with substance use disorder
  • What’s new in HIV prevention and management
  • The latest on COVID-19, including long COVID

As revised treatment strategies, new diagnostic tests, and guidelines are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work.

Highlights of the 2025 Program

Expanded Case-Based and Problem-Solving Education 

The 2025 program features an expanded range of interactive, case-based, and problem-solving education. The formats are engaging, and attendees are encouraged to pose questions to our national experts in live question-and-answer sessions following the lectures and the multidisciplinary workshops. Our speakers and panelists include not only ID experts, but those from fields such as pharmacy, surgery, radiology, cardiology, pulmonology, and addiction medicine, thereby providing a 360-degree context for the understanding of ID treatment and patient care. Our ten multidisciplinary workshops include complicated urinary tract and intra-abdominal infections, native and prosthetic valve endocarditis, musculoskeletal infections, and nontuberculous mycobacterial infections.

Treating Highly Resistant Infections, including:

  • MRSA and VISA (vancomycin-intermediate Staph aureus)
  • Extended-spectrum beta-lactamase (ESBL)-producing Gram-negative rods
  • Carbapenemase-producing Gram-negative rods, including NDM-1 metallo-beta-lactamase-producing organisms
  • Vancomycin-resistant enterococci (VRE)
  • Aspergillus and non-aspergillus mold infections
  • Candida auris
  • Nontuberculous mycobacteria (NTM)

Common Infectious Diseases: Updates in Prevention, Diagnosis, and Treatment

Updates to keep you current on new strategies, state-of-the-art practices, and the most recent guidelines to address:

  • Respiratory viral infections, including COVID-19
  • New and updated vaccines
  • Infections in the expanding populations of immunocompromised hosts
  • Infections in persons with substance use disorder
  • Infections of travelers and foreign-born persons
  • Systemic fungal infections
  • Native and device-related orthopedic infections
  • Central nervous system (CNS) infections
  • Ear, nose, and throat (ENT) and eye infections
  • Skin and soft tissue infections
  • Bronchiectasis and pneumonia
  • HIV and its infectious and noninfectious complications
  • PEP (Post-Exposure Prophylaxis) and PrEP (Pre-Exposure Prophylaxis) to prevent HIV infection
  • Sexually transmitted infections (STIs), including mpox and PEP for prevention of STIs
  • Hepatitis B and C infections
  • Tick- and mosquito-borne infections
  • Clostridioides difficile infection
  • Complicated urinary tract infections
  • Intra-abdominal infections

Challenging, Rare, and Emerging Infectious Diseases

Comprehensive updates on:

  • Rare and emerging infectious diseases, including highly pathogenic avian flu and Marburg virus
  • Re-emergence of vaccine-preventable diseases, including poliomyelitis
  • Pulmonary and extrapulmonary non-tuberculous (“atypical”) mycobacteria, including Mycobacterium abscessus
  • Global infectious diseases of clinical importance

Clinical Decision-Making

Hear directly from world-renowned specialists and master clinicians on their approach and decision-making criteria for:

  • Selecting the best antimicrobial and duration of treatment
  • Rapid detection and empiric treatment of life-threatening infectious diseases
  • Choosing between inpatient and outpatient treatment, and between intravenous and oral antimicrobials
  • Optimizing empiric antimicrobial therapy: what to start, and when to narrow or stop

Our multidisciplinary talks and workshops incorporate safety, quality, and practice improvement in infectious diseases, including:

  • Antimicrobial stewardship to prevent resistance and reduce cost
  • Infection control to reduce transmission in health care settings
  • Early inpatient ID consultations to improve outcomes
  • Strategies for management of infection in persons who inject drugs (PWID)

Optimized for Remote Education

The 2025 program has been enhanced for distance learning. In addition to being live streamed, all session recordings will be made available to participants for online viewing for 90 days after the end of the course.

New in 2025

The 2025 program adds coverage of:

  • Vaccine updates
  • The latest on respiratory viral infections
  • Infectious disease outbreaks of concern: highly pathogenic avian flu and Marburg virus
  • ID and critical care

Who Should Attend

Physicians, Nurse Practitioners, Physician Assistants, and Pharmacists in the fields of:

  • Infectious Diseases
  • Hospital Medicine
  • Internal Medicine
  • Family Practice
  • Pulmonary and Critical Care Medicine
  • Emergency Medicine

…and others who care for patients with infectious diseases

 

+ Topics:

1. Schedule.pdf

2. Uyeki Plenary will not be recorded (please read).pdf

3. CPC Embargo (please read).pdf

Day 1 An Antibiotic Allergy Toolkit.mp4

Day 1 An Antibiotic Allergy Toolkit.pdf

Day 1 Antimicrobial Stewardship.mp4

Day 1 Antimicrobial Stewardship.pdf

Day 1 Clostridioides difficile Infection, Including Recurrent and Refractory Disease and Novel Approaches.mp4

Day 1 Clostridioides difficile Infection, Including Recurrent and Refractory Disease and Novel Approaches.pdf

Day 1 Infection Control 101 for the ID Clinician.mp4

Day 1 Infection Control 101 for the ID Clinician.pdf

Day 1 Introduction and Road Map Infectious Diseases of Adults.mp4

Day 1 Introduction and Road Map Infectious Diseases of Adults.pdf

Day 1 Live Q & A 1.mp4

Day 1 Live Q & A 2.mp4

Day 1 Live Q & A 3.mp4

Day 1 Live Q & A 4.mp4

Day 1 Panel Workshop #1 Resistant Gram-Positive Infections.mp4

Day 1 Panel Workshop #1 Resistant Gram-Positive Infections.pdf

Day 1 Panel Workshop #2 Resistant Gram-Negative Infections.mp4

Day 1 Panel Workshop #2 Resistant Gram-Negative Infections.pdf

Day 1 Plenary Highly Pathogenic Avian Influenza Uyeki Plenary will not be recorded (please read).pdf

Day 1 Principles of Antimicrobial Therapy.mp4

Day 1 Principles of Antimicrobial Therapy.pdf

Day 1 Skin and Soft Tissue Infections.mp4

Day 1 Skin and Soft Tissue Infections.pdf

Day 1 Update on Antifungal Diagnostics and Therapy.mp4

Day 1 Update on Antifungal Diagnostics and Therapy.pdf

Day 2 Bone and Joint Infections A Conceptual Framework.mp4

Day 2 Bone and Joint Infections A Conceptual Framework.pdf

Day 2 Encephalitis and Meningitis The Newest Guidelines and Best.mp4

Day 2 Encephalitis and Meningitis The Newest Guidelines and Best.pdf

Day 2 Keynote Lecture-Protecting Public Health with Vaccines Understanding Our Past, Protecting Our Future.mp4

Day 2 Keynote Lecture-Protecting Public Health with Vaccines Understanding Our Past, Protecting Our Future.pdf

Day 2 Live Q & A 1.mp4

Day 2 Live Q & A 2.mp4

Day 2 Live Q & A 3.mp4

Day 2 New and Emerging Viruses.mp4

Day 2 New and Emerging Viruses.pdf

Day 2 Panel Workshop #3 Native Bone Infections.mp4

Day 2 Panel Workshop #3 Native Bone Infections.pdf

Day 2 Panel Workshop #4 Orthopedic Device Infections Prosthetic Joint Infections.mp4

Day 2 Panel Workshop #4 Orthopedic Device Infections Prosthetic Joint Infections.pdf

Day 2 Staphylococcus aureus D‚j… Vu All Over Again.mp4

Day 2 Staphylococcus aureus D‚j… Vu All Over Again.pdf

Day 2 State-of-the-Art Diagnosis and Management of Sexually Transmitted Infections.mp4

Day 2 State-of-the-Art Diagnosis and Management of Sexually Transmitted Infections.pdf

Day 2 Tick Talk Lyme Disease, Ehrlichia, Anaplasma, Babesia, Rickettsia, and Other Tick-Borne Infections.mp4

Day 2 Tick Talk Lyme Disease, Ehrlichia, Anaplasma, Babesia, Rickettsia, and Other Tick-Borne Infections.pdf

Day 3 Advances in Viral Hepatitis HBV and HCV.mp4

Day 3 Advances in Viral Hepatitis HBV and HCV.pdf

Day 3 Critical Care ID.mp4

Day 3 Critical Care ID.pdf

Day 3 Endocarditis and Cardiac Device Infections.mp4

Day 3 Endocarditis and Cardiac Device Infections.pdf

Day 3 Live Q & A 1.mp4

Day 3 Live Q & A 2.mp4

Day 3 Live Q & A 3.mp4

Day 3 Live Q & A 4.mp4

Day 3 Panel Workshop #5 Multidisciplinary Management of Intraabdominal Infections (Including New Guidelines).mp4

Day 3 Panel Workshop #5 Multidisciplinary Management of Intraabdominal Infections (Including New Guidelines).pdf

Day 3 Panel Workshop #6 Challenges in Native Valve Endocarditis (Including in Persons with Substance Use Disorder).mp4

Day 3 Panel Workshop #6 Challenges in Native Valve Endocarditis (Including in Persons with Substance Use Disorder).pdf

Day 3 Panel Workshop #7 Multidisciplinary Management of Prosthetic Valve Endocarditis (Including in Persons with Substance Use Disorder).mp4

Day 3 Panel Workshop #7 Multidisciplinary Management of Prosthetic Valve Endocarditis (Including in Persons with Substance Use Disorder).pdf

Day 3 Panel Workshop #8 Multidisciplinary Management of Complex Urinary Tract Infections.mp4

Day 3 Panel Workshop #8 Multidisciplinary Management of Complex Urinary Tract Infections.pdf

Day 3 The Syndemic of SUD and Infection Updated Approaches for 2025.mp4

Day 3 The Syndemic of SUD and Infection Updated Approaches for 2025.pdf

Day 4 Cellular and Immune-Based Therapies for Cancer 2025 What the ID Clinician Needs to Know.mp4

Day 4 Cellular and Immune-Based Therapies for Cancer 2025 What the ID Clinician Needs to Know.pdf

Day 4 Flummoxing Cases in Fungal Infections.mp4

Day 4 Flummoxing Cases in Fungal Infections.pdf

Day 4 Infections in Hematologic Malignancies and Stem Cell Transplantation.mp4

Day 4 Infections in Hematologic Malignancies and Stem Cell Transplantation.pdf

Day 4 Infections Related to Solid Organ Transplant and Non-Oncologic Immunomodulatory Therapy.mp4

Day 4 Infections Related to Solid Organ Transplant and Non-Oncologic Immunomodulatory Therapy.pdf

Day 4 Live Q & A 1.mp4

Day 4 Live Q & A 2.mp4

Day 4 Live Q & A 3.mp4

Day 4 Navigating New Vaccines Updates and Recommendations.mp4

Day 4 Navigating New Vaccines Updates and Recommendations.pdf

Day 4 Pre- and Post-Exposure Prophylaxis for HIV and STIs.mp4

Day 4 Pre- and Post-Exposure Prophylaxis for HIV and STIs.pdf

Day 4 Understanding and Addressing the Continuing Challenges in HIVAssociated Opportunistic Infections.mp4

Day 4 Understanding and Addressing the Continuing Challenges in HIVAssociated Opportunistic Infections.pdf

Day 4 Updates on COVID-19, Including Long COVID-19.mp4

Day 4 Updates on COVID-19, Including Long COVID-19.pdf

Day 4 What’s New in the Care of People with HIV in 2025.mp4

Day 4 What’s New in the Care of People with HIV in 2025.pdf

Day 5 Bronchiectasis, Pneumonia, and NTM Infections Anatomic and Clinical Approaches.mp4

Day 5 Bronchiectasis, Pneumonia, and NTM Infections Anatomic and Clinical Approaches.pdf

Day 5 Cases in Global Infectious Diseases.mp4

Day 5 Cases in Global Infectious Diseases.pdf

Day 5 Eye and ENT Infections What You Need to Know in 2025.mp4

Day 5 Eye and ENT Infections What You Need to Know in 2025.pdf

Day 5 Full Live.mp4

Day 5 Kim – Viral Hepatitis.pdf

Day 5 Live New England Journal of Medicine Clinicopathologic Conference (CPC) NEJM CPC Embargo (please read).pdf

Day 5 Live New England Journal of Medicine Clinicopathologic Conference (CPC) NEJM CPC Presentation of Case – audience only.pdf

Day 5 Panel Workshop #10 Management of Complex Nontuberculous Mycobacterial (NTM) Infection Extrapulmonary.mp4

Day 5 Panel Workshop #10 Management of Complex Nontuberculous Mycobacterial (NTM) Infection Extrapulmonary.pdf

Day 5 Panel Workshop #9 Management of Complex Nontuberculous Mycobacterial (NTM) Infection Pulmonary.mp4

Day 5 Panel Workshop #9 Management of Complex Nontuberculous Mycobacterial (NTM) Infection Pulmonary.pdf

Day 5 The Latest on Major Respiratory Viral Infections.mp4

Day 5 The Latest on Major Respiratory Viral Infections.pdf

Day 5 Tropical Medicine 2025 Review and Update.mp4

Day 5 Tropical Medicine 2025 Review and Update.pdf

Day 5 Tuberculosis Update.mp4

Day 5 Tuberculosis Update.pdf

Harvard CME _ Infectious Diseases in Adults.pdf

NEJM CPC Embargo Notice.pdf

Reviews

There are no reviews yet.

Be the first to review “Harvard Infectious Diseases In Adults 2025”

Your email address will not be published. Required fields are marked *

Related Products